Please login to the form below

Not currently logged in

NHS Commissioning Board appoints 16 local directors

They will provide oversight as new system is implemented across England

England's NHS Commissioning Board has appointed the first 16 of its local directors who will lead the support of clinical commissioning groups and provide an oversight of the new system of commissioning currently being implemented across the country as part of the Health Bill.

Under this new legislation, commissioning control is being handed from primary care trusts and strategic health authorities to GPs, with the NHS Commissioning Board set up to provide national standards and accountability, and ensure the system is “fit for purpose”.

According the NHS Commissioning Board, the new local directors will work with clinical commissioning groups, providing such functions as emergency planning, quality and safety arrangements and stakeholder engagement. The local director will also be a partner on the appropriate health and wellbeing board.

In addition, each local team will support the commissioning of GP services, dental services, pharmacy and certain aspects of optical services.

Once the NHS Commissioning Board takes on full responsibilities in April, 2013, there will be 27 local teams across the country, although the three London teams will be managed by one director, meaning only 25 local directors are to be hired in total.

The remaining nine positions will be filled after a second round of advertising and interviews.

Ian Dalton, chief operating officer and deputy chief executive of the NHS Commissioning Board Authority said: “I am delighted that we have made these key appointments to such important leadership posts.

“This puts us in a position to quickly develop the local presence of the NHS Commissioning Board, building strong relationships with our partners and communities to firmly focus on driving improvement for our patients.”

The appointments so far are:

• Cheshire, Warrington and Wirral: Moira Dumma (currently director of commissioning development at NHS Midlands and East SHA Cluster)
• Merseyside: Clare Duggan (currently director of strategic change at NHS Merseyside PCT Cluster)
• Greater Manchester: Mike Burrows (currently chief executive of NHS Greater Manchester PCT Cluster)
• South Yorkshire and Bassetlaw: Andy Buck (currently chief executive of NHS South Yorkshire and Bassetlaw PCT Cluster)
• North Yorkshire and Humber: Chris Long (currently chief executive of NHS North Yorkshire and York PCT Cluster and NHS Humberside PCT Cluster)
• Durham, Darlington and Tees: Cameron Ward (currently director of commissioning development at NHS North of England SHA Cluster)

Midlands and East
• Essex: Andrew Pike (currently chief executive of South Essex PCT Cluster)
• Hertfordshire and the South Midlands: Jane Halpin (currently chief executive of NHS Hertfordshire PCT Cluster)
• Leicestershire and Lincolnshire: David Sharp (currently chief executive of NHS Derbyshire PCT Cluster)
• Derbyshire and Nottinghamshire: Derek Bray (currently chief executive of NHS Nottinghamshire PCT Cluster)
• Shropshire and Staffordshire: Graham Urwin (currently chief executive of NHS Staffordshire PCT Cluster)
• Birmingham and the Black Country: Wendy Saviour (currently director of partnerships at NHS Commissioning Board Authority)

• London: Simon Weldon (currently director of operations and delivery at North West London Commissioning Partnership)

South of England
• Surrey and Sussex: Amanda Fadero (currently chief executive of NHS Sussex PCT Cluster)
• Wessex:  Debbie Fleming (currently chief executive of Southampton, Hampshire, Isle of Wight and Portsmouth PCT Cluster)
• Devon, Cornwall and Isles of Scilly: Ann James (currently chief executive of NHS Devon, Plymouth and Torbay PCT Cluster).

23rd July 2012


Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 is a global healthcare technology company and an effective digital communications platform, which is supported by strong communities and...

Latest intelligence

Market access in Europe: balancing access and affordability
European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new drugs...
Introduction to the manufacturing of biologics
The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the...
CES 2017 – Medical Device Top Picks
Connected tech was the overriding theme at this year's Consumer Electronics Show in Las Vegas. But among all that consumer gadgetry, there were some great medical devices too. So what...